Sputum clinical trials

Explore recruiting sputum clinical trials.

Recruiting sputum studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sputum trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Inhaled ColiFin® in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection – an open-label, proof of concept - randomized controlled trial (DZL-Eradicate)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Benefits of inhalation of 7% hypertonic saline solution prior to ELTGOL physiotherapy, in patients with bronchiectasis. A randomized controlled trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection

Germany, Ireland, France, Czechia, Italy, Netherlands +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Low Intervention, Open, Multicentric, Phase IV Exploratory Clinical Trial to evaluate new biomarkers for the diagnosis and treatment monitoring of tuberculosis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of the early bactericidal activity of tedizolid and linezolide against Mycobacterium tuberculosis (TEDITUB)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-label randomized study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sputum trials by city

Sputum in Toronto Sputum in Vancouver Sputum in Montreal Sputum in Calgary Sputum in Edmonton Sputum in Ottawa Sputum in Winnipeg Sputum in Quebec City Sputum in Hamilton Sputum in Kitchener Sputum in London Sputum in Halifax Sputum in New York Sputum in Los Angeles Sputum in Chicago Sputum in Houston

Sputum clinical trials

Recruiting sputum studies right now

Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China

Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients

Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial

Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patient With Cervical Spinal Cord Injuries

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Sputum Cytometry Guided Management for the Elimination of Chronic Cough in Patients With ILD

Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial

Effect of Ensifentrine on Sputum Markers of Inflammation in COPD

Electromagnetic High-Frequency Chest Wall Oscillation on Pulmonary Mucus Clearance in Patients With Impaired Self-Expectoration

Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

Also recruiting in Europe

Inhaled ColiFin® in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection – an open-label, proof of concept - randomized controlled trial (DZL-Eradicate)

Benefits of inhalation of 7% hypertonic saline solution prior to ELTGOL physiotherapy, in patients with bronchiectasis. A randomized controlled trial.

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection

Low Intervention, Open, Multicentric, Phase IV Exploratory Clinical Trial to evaluate new biomarkers for the diagnosis and treatment monitoring of tuberculosis

Evaluation of the early bactericidal activity of tedizolid and linezolide against Mycobacterium tuberculosis (TEDITUB)

AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-label randomized study

Sputum trials by city

Other conditions